Characterising People Who Inject Drugs, and Association with HIV Infection: A Situation Analysis in Kampala City, Uganda

Overview

Journal PLOS Glob Public Health

Specialty Public Health

Date 2025 Feb 26

PMID 40009634

Authors

Peter Mudiope

Bradley Mathers

Joanita Nangendo

Samuel Mutyaba

Byamah B Mutamba

Stella Alamo

Nicholus Nanyenya

Fredrick Makumbi

Miriam Laker-Oketta

Rhoda Wanyenze

Affiliations

Soon will be listed here.

Abstract

Uganda implements interventions for injection drug use, but significant barriers hinder efforts to effectively reach and support persons who inject drugs (PWID). We describe characteristics of PWID, and associated risk behaviour, to inform the designing of programmes that are tailored to clients' needs and preferences. A cross-sectional survey (August 23rd to December 5th, 2023) in Kampala interviewed 354 PWID (≥18-years) at selected venues(bars,lodges, street corners and ghetto). Peer eductors and counsellors administered a structured questionnaire covering socio-demographics, drug use, sexual risk, and medical history. HIV serostatus was determined by self-report or testing for consenting participants without history of recent testing Binary logistic regression was used to establish the relationship between HIV infection and risky drug- and sexual behaviour of PWID. Participants were predominantly Ugandan (95.2%), male (73.2%), unmarried (55.9%), unemployed (81.8%), with higher levels of education and varying ages. Mental disorders were prevalent, with 48.7% reporting at least one underlying condition, including depression (30.8%) and anxiety (9.6%). Physical health issues included fever (32.9%), cough (32.5%), malaria (22%), and sexually transmitted infections (15%). Over 82.6% were introduced to drugs by close acquaintances. HIV prevalence among participants was 3.7%, higher in females (8.4%) and non-Ugandans (16.7%). Being female and experiencing difficulty accessing sterile injection materials were associated with HIV-positive status. Our study provides valuable insight into the socio-demographic, mental, physical health, and HIV risk behaviour of PWID in Kampala, Uganda. The findings indicate significant vulnerabilities to injecting drug use, mental disorders, and high-risk behaviors that predispose this population to HIV infection. Despite a low HIV prevalence in this population compared to previous estimates, the interplay between drug use, risky injecting practices, and sexual behaviour suggests an urgent need for targeted interventions to address these intertwined challenges.

References

Dua T, Barbui C, Clark N, Fleischmann A, Poznyak V, van Ommeren M . Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations. PLoS Med. 2011; 8(11):e1001122. PMC: 3217030. DOI: 10.1371/journal.pmed.1001122. View

Mudiope P, Mutamba B, Komuhangi L, Nangendo J, Alamo S, Mathers B . Retention of people who inject drugs enrolled in a 'medications for opioid use disorder' (MOUD) programme in Uganda. Addict Sci Clin Pract. 2024; 19(1):39. PMC: 11094991. DOI: 10.1186/s13722-024-00468-4. View

Lion R, Watt M, Wechsberg W, Meade C . Gender and Sex Trading Among Active Methamphetamine Users in Cape Town, South Africa. Subst Use Misuse. 2017; 52(6):773-784. PMC: 5600888. DOI: 10.1080/10826084.2016.1264964. View

Atkinson J, McCurdy S, Williams M, Mbwambo J, Kilonzo G . HIV risk behaviors, perceived severity of drug use problems, and prior treatment experience in a sample of young heroin injectors in Dar es Salaam, Tanzania. Afr J Drug Alcohol Stud. 2012; 10(1):1-9. PMC: 3460543. View

Dickson-Gomez J, Twaibu W, Christenson E, Dan K, Anguzu R, Homedi E . Injection and sexual risk among people who use or inject drugs in Kampala, Uganda: An exploratory qualitative study. PLoS One. 2020; 15(4):e0231969. PMC: 7176107. DOI: 10.1371/journal.pone.0231969. View

Williams M, McCurdy S, Bowen A, Kilonzo G, Atkinson J, Ross M . HIV seroprevalence in a sample of Tanzanian intravenous drug users. AIDS Educ Prev. 2009; 21(5):474-83. PMC: 2862568. DOI: 10.1521/aeap.2009.21.5.474. View

Minh K, Vallo R, Duong Thi H, Hai O, Des Jarlais D, Peries M . Psychiatric Comorbidities among People Who Inject Drugs in Hai Phong, Vietnam: The Need for Screening and Innovative Interventions. Biomed Res Int. 2018; 2018:8346195. PMC: 6193349. DOI: 10.1155/2018/8346195. View

Levitt A, Mermin J, Jones C, See I, Butler J . Infectious Diseases and Injection Drug Use: Public Health Burden and Response. J Infect Dis. 2020; 222(Suppl 5):S213-S217. DOI: 10.1093/infdis/jiaa432. View

Opio J, Munn Z, Aromataris E . Prevalence of Mental Disorders in Uganda: a Systematic Review and Meta-Analysis. Psychiatr Q. 2021; 93(1):199-226. DOI: 10.1007/s11126-021-09941-8. View

10.

Degenhardt L, Webb P, Colledge-Frisby S, Ireland J, Wheeler A, Ottaviano S . Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review. Lancet Glob Health. 2023; 11(5):e659-e672. DOI: 10.1016/S2214-109X(23)00057-8. View

11.

Handanagic S, Bozicevic I, civljak M, Dominkovic Z, Sevic S, Barbaric J . HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys. Int J Drug Policy. 2016; 32:57-63. DOI: 10.1016/j.drugpo.2016.04.007. View

12.

Montgomery S, Hyde J, De Rosa C, Rohrbach L, Ennett S, Harvey S . Gender differences in HIV risk behaviors among young injectors and their social network members. Am J Drug Alcohol Abuse. 2002; 28(3):453-75. DOI: 10.1081/ada-120006736. View

13.

Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P . Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017; 5(12):e1192-e1207. PMC: 5683738. DOI: 10.1016/S2214-109X(17)30375-3. View

14.

Mutiso V, Musyimi C, Rebello T, Gitonga I, Tele A, Pike K . Patterns of concordances in mhGAP-IG screening and DSM-IV/ICD10 diagnoses by trained community service providers in Kenya: a pilot cross-sectional study. Soc Psychiatry Psychiatr Epidemiol. 2018; 53(11):1277-1287. DOI: 10.1007/s00127-018-1567-1. View

15.

Mutiso V, Musyimi C, Tomita A, Loeffen L, Burns J, Ndetei D . Epidemiological patterns of mental disorders and stigma in a community household survey in urban slum and rural settings in Kenya. Int J Soc Psychiatry. 2017; 64(2):120-129. PMC: 5836746. DOI: 10.1177/0020764017748180. View

16.

Tapert S, Aarons G, Sedlar G, Brown S . Adolescent substance use and sexual risk-taking behavior. J Adolesc Health. 2001; 28(3):181-9. DOI: 10.1016/s1054-139x(00)00169-5. View

17.

Riondel A, Huong D, Michel L, Peries M, Oanh K, Khue P . Towards Targeted Interventions in Low- and Middle-Income Countries: Risk Profiles of People Who Inject Drugs in Haiphong (Vietnam). Biomed Res Int. 2020; 2020:8037193. PMC: 7502134. DOI: 10.1155/2020/8037193. View

18.

Brookmeyer K, Haderxhanaj L, Hogben M, Leichliter J . Sexual risk behaviors and STDs among persons who inject drugs: A national study. Prev Med. 2019; 126:105779. PMC: 6816039. DOI: 10.1016/j.ypmed.2019.105779. View

19.

Lambdin B, Masao F, Chang O, Kaduri P, Mbwambo J, Magimba A . Methadone treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study. Clin Infect Dis. 2014; 59(5):735-42. PMC: 4809981. DOI: 10.1093/cid/ciu382. View

20.

Ochonye B, Folayan M, Fatusi A, Bello B, Ajidagba B, Emmanuel G . Sexual practices, sexual behavior and HIV risk profile of key populations in Nigeria. BMC Public Health. 2019; 19(1):1210. PMC: 6721228. DOI: 10.1186/s12889-019-7553-z. View